128 related articles for article (PubMed ID: 4607883)
1. Phase I clinical trial of combined therapy with 5-FU (NSC 19893) and CIS-platinum (II) diaminedichloride (NSC 119875).
Ellerby RA; Davis HL; Ansfield FJ; Ramirez G
Cancer; 1974 Oct; 34(4):1005-10. PubMed ID: 4607883
[No Abstract] [Full Text] [Related]
2. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
Scheithauer W; Depisch D; Kornek G; Pidlich J; Rosen H; Karall M; Prochaska M; Ernst A; Sebesta C; Eckhardt S
Cancer; 1994 Mar; 73(6):1562-8. PubMed ID: 8156482
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
Piel IJ; Perlia CP
Cancer Chemother Rep; 1975; 59(5):995-9. PubMed ID: 1106849
[TBL] [Abstract][Full Text] [Related]
6. [Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer].
Rivière A; Abouz D; Ayela P; Berthaud P; Frenay M; Lagrange JL; Pujol JL; Robillard J; Le Chevalier T
Bull Cancer; 1989; 76(10):1095-102. PubMed ID: 2561418
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
Stephens RL; Hoogstraten B
Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
[No Abstract] [Full Text] [Related]
8. A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck.
Kish JA; Ensley JF; Jacobs J; Weaver A; Cummings G; Al-Sarraf M
Cancer; 1985 Dec; 56(12):2740-4. PubMed ID: 3902199
[TBL] [Abstract][Full Text] [Related]
9. Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study.
Tranum BL; Stephens RL; Lehane DE; Hoogstraten B; Lane M; Haut A
Cancer Chemother Rep; 1975; 59(6):1163-5. PubMed ID: 769959
[No Abstract] [Full Text] [Related]
10. Cis-diamminedichloroplatinum (NSC-119875): a phase I study.
Higby DJ; Wallace HJ; Holland JF
Cancer Chemother Rep; 1973; 57(4):459-63. PubMed ID: 4586953
[No Abstract] [Full Text] [Related]
11. Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.
Hill JM; Loeb E; MacLellan A; Hill NO; Khan A; King JJ
Cancer Chemother Rep; 1975; 59(3):647-59. PubMed ID: 1203889
[TBL] [Abstract][Full Text] [Related]
12. cis-Dichlorodiammineplatinum(II) in childhood cancer.
Freeman AI; Ettinger LJ; Brecher ML
Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
[TBL] [Abstract][Full Text] [Related]
13. Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinoma.
Long HJ; Nelimark RA; Su JQ; Garneau SC; Levitt R; Goldberg RM; Poon MA; Kugler JW
Gynecol Oncol; 1994 Aug; 54(2):180-3. PubMed ID: 8063243
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
[TBL] [Abstract][Full Text] [Related]
15. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
16. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
[TBL] [Abstract][Full Text] [Related]
17. Review of the current clinical status of platinum coordination complexes in cancer chemotherapy.
Gottlieb JA; Drewinko B
Cancer Chemother Rep; 1975; 59(3):621-8. PubMed ID: 1106840
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids and fluorouracil toxicity.
Horton J; Olson KB; Hosley HF
Arch Intern Med; 1966 Jun; 117(6):775-7. PubMed ID: 5327216
[No Abstract] [Full Text] [Related]
19. Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease.
Weiss AJ; Mastrangelo MJ
Cancer Chemother Rep; 1970 Apr; 54(2):109-11. PubMed ID: 4946000
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of toxic effects of cis-diamminedichloroplatinum (NSC-119875)--phase I clinical study.
Talley RW; O'Bryan RM; Gutterman JU; Brownlee RW; McCredie KB
Cancer Chemother Rep; 1973; 57(4):465-71. PubMed ID: 4762440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
